Metraipolis › archive › dc_f56fd828c6dc

Factors influencing Anti-SARS-CoV-2 IgG levels after vaccination in breast cancer patients — Europe PMC PMID:41639359

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41639359
DOI
10.1007/s12672-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-06T03:03:07.082Z
SHA-256 of the archived text
617415bc526ada9c32e8f622049fe3e3202832df2fa82891ab7c8a522081091f
Stable URL of this page
https://metraipolis.com/documento/dc_f56fd828c6dc

How to cite

Factors influencing Anti-SARS-CoV-2 IgG levels after vaccination in breast cancer patients — Europe PMC PMID:41639359 — Europe PMC (en), https://europepmc.org/article/MED/41639359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f56fd828c6dc (Metraipolis archive dc_f56fd828c6dc, sha256 617415bc526ada9c32e8f622049fe3e3202832df2fa82891ab7c8a522081091f)
BibTeX
@misc{dcf56fd828c6dc,
  title = {Factors influencing Anti-SARS-CoV-2 IgG levels after vaccination in breast cancer patients — Europe PMC PMID:41639359},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41639359},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f56fd828c6dc; sha256 617415bc526ada9c32e8f622049fe3e3202832df2fa82891ab7c8a522081091f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41639359. Agents can read the archived copy with the MCP tool read_document.